Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice
- PMID: 2824265
- DOI: 10.1007/BF00292545
Factors affecting the infection of the D variant of encephalomyocarditis virus in the B cells of C57BL/6J mice
Abstract
The D variant of encephalomyocarditis virus is capable of infecting most inbred strains of mice. However, only certain strains are susceptible to the diabetogenic effect of this virus. In order to understand why some inbred strains do not become diabetic, the pathogenesis of infection was studied in diabetes-resistant C57BL/6J mice. It was the purpose of the investigation to ascertain whether specific host defense factors might play a crucial role in the mechanism of resistance. To determine whether perturbations of the immune response would alter the resistance of these animals, mice were treated with a high dose (1.15 mmol/kg body weight) of the T- and B-cell toxin cyclophosphamide prior to infection with the D variant. This treatment did not induce overt diabetes or glucose intolerance in the mice tested 7 days after infection. Based on this finding, it appeared likely that resistance to the D variant is conveyed by some factor other than cell-mediated immunity. A likely candidate to control this viral infection is the interferon system. To investigate this possibility, C57BL/6J mice were infected with the D variant and the concentrations of serum interferon titred at various intervals thereafter. In contrast to previous reports with diabetes susceptible mice, C57BL/6J mice were found to generate a substantial interferon response against this variant, with peak levels found in the serum at 24 h following infection. Additional studies were performed in which mice were treated with antibody to mouse interferon alpha/beta at the time of infection and again 3 days after infection with the D variant.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice.Viral Immunol. 1990 Spring;3(1):67-76. doi: 10.1089/vim.1990.3.67. Viral Immunol. 1990. PMID: 2153386
-
Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus.Diabetes. 1987 Dec;36(12):1408-13. doi: 10.2337/diab.36.12.1408. Diabetes. 1987. PMID: 2824259
-
Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice.Diabetologia. 1986 May;29(5):313-20. doi: 10.1007/BF00452069. Diabetologia. 1986. PMID: 3013707
-
Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.Rev Infect Dis. 1987 Sep-Oct;9(5):917-24. doi: 10.1093/clinids/9.5.917. Rev Infect Dis. 1987. PMID: 2825321 Review.
-
The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.Dan Med Bull. 1985 Jun;32(3):139-51. Dan Med Bull. 1985. PMID: 3160550 Review.
Cited by
-
Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.J Virol. 1990 May;64(5):2187-92. doi: 10.1128/JVI.64.5.2187-2192.1990. J Virol. 1990. PMID: 2157880 Free PMC article.
-
Innate immune response to encephalomyocarditis virus infection mediated by CD1d.Immunology. 2003 Dec;110(4):519-26. doi: 10.1111/j.1365-2567.2003.01779.x. Immunology. 2003. PMID: 14632651 Free PMC article.
-
Effects of type I interferons on Friend retrovirus infection.J Virol. 2006 Apr;80(7):3438-44. doi: 10.1128/JVI.80.7.3438-3444.2006. J Virol. 2006. PMID: 16537611 Free PMC article.